Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer

Eva Asamer,Joanna Szkandera,Paul Gibiser,Anna L. Lembeck,Tatjana Stojakovic,Peter Kornprat,C. Lackner,Thomas Winder,Konstantin Schlick,Herbert Stöger,Armin Gerger,Martin Pichler,Michael Stotz

Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer

2018

Eva Asamer
Joanna Szkandera
Paul Gibiser
Anna L. Lembeck
Tatjana Stojakovic
Peter Kornprat
C. Lackner
Thomas Winder
Konstantin Schlick
Herbert Stöger
Armin Gerger
Martin Pichler
Michael Stotz

Background and aim The aim of this study was to investigate the prognostic relevance of plasma amylase and lipase concerning survival of patients suffering from metastatic pancreatic cancer (PC).

Keywords:

Metastatic pancreatic cancer
Gastroenterology
Amylase
Pathology
Lipase
Pancreatitis
CA19-9
Diabetes mellitus
Adenocarcinoma
Medicine
Pancreas
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations